New study aims to find safe fasting time for diabetics on Weight-Loss drugs before surgery
NCT ID NCT07506356
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how long people with type 2 diabetes need to stop taking GLP-1 medications (like semaglutide) before surgery to make sure their stomach is empty. These drugs slow down digestion, which can increase the risk of food or liquid entering the lungs during anesthesia. Researchers will use ultrasound to measure stomach volume in 38 participants after a 6-hour fast, 7 days after their last injection. The goal is to find a safe waiting period for surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETE TYPE 2 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hôpitaux Universitaires de Genève
RECRUITINGGeneva, Canton of Geneva, 1211, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gamifying exercise: could a phone app outperform traditional programs for obesity and diabetes?
- Can your DNA predict how you respond to a diabetes drug?
- Antioxidant-rich diets may fight inflammation in type 2 diabetes — a study investigates
- Can two experimental pills work together safely? a trial seeks answers
- Could meal kits and text messages help curb diabetes in Food-Insecure communities?
- Walking downhill may boost heart health and strength in type 2 diabetes